Therapixel
PrivateLast Round
Series B
May 12, 2022
Total Funding Raised
$23.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Therapixel operates in Healthcare & Life Sciences and is based in Nice. Its latest recorded funding round was a Series B round in May 2022.
Therapixel is a healthtech company that provides AI-based medical imaging software to assist radiologists in breast cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Computer Vision
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therapixel Comparables
Compare Therapixel with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ScreenPoint Medical | 94% | |
| Vara | 91% | |
| DeepLook Medical | 88% |
For institutional investors. Book with your work email.
Therapixel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 12, 2022 | ||||
| Series A | Mar 13, 2019 | ||||
| Grant | Jun 2, 2017 | ||||
| Seed | Nov 21, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Therapixel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CapHorn Invest | Series B |
| Verve Ventures | Series B |
| Région Sud Investissement | Seed, Series A, Series B |
| Turenne Groupe | Seed |
| Arnold Ventures | Grant |
| M Capital | Series B, Series A |
| Crédit Mutuel Innovation | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 246% MoM.
- Oct 1, 2025
Operating within CE mark and FDA regulated environment.
For institutional investors. Book with your work email.
Therapixel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Therapixel's valuation, stock price, and market status.
Is Therapixel a public or private company?
Therapixel is a private company.
What is the current stock price of Therapixel?
Therapixel is a private company, so its shares have no public market price. Caplight tracks Therapixel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Therapixel worth (valuation)?
Valuation information for Therapixel is not publicly available.
Can I buy Therapixel stock?
Therapixel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Therapixel's last funding round?
Therapixel's most recent funding round was Series B on May 12, 2022.
Who are the main investors in Therapixel?
Key investors in Therapixel include CapHorn Invest, M Capital, Crédit Mutuel Innovation, Omnes Capital.
Will Therapixel IPO soon?
No public IPO plans have been announced for Therapixel.
How can I track Therapixel secondary market activity?
Caplight tracks bids, offers, and trades in Therapixel's shares on secondary markets.